Picture of Orexo AB logo

ORX Orexo AB Income Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Orexo AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue664565624639590
Cost of Revenue
Gross Profit598486522550518
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses684779808748730
Operating Profit-19.9-214-184-110-140
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-38.3-223-170-140-191
Provision for Income Taxes
Net Income After Taxes-84.4-224-178-128-203
Net Income Before Extraordinary Items
Net Income-84.4-224-178-128-203
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-84.4-224-178-128-203
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.861-0.654-1.9-1.45-5.89
Dividends per Share